Recent progress on anti-liver fibrosis candidates in patents of herbal medicinal products

Recent Patents on Food, Nutrition and Agriculture

Volumn 4, Issue 2, 2012, Pages 91-106

  Wang, Xuan Bin ^a,b   Feng, Yibin ^a   Wang, Ning ^a   Cheung, Fan ^a   Wong, Chi Woon ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Anti liver fibrosis; Chinese medicines; Complementary and alternative medicines; Herbal medicines; Patent

Indexed keywords

PLANT EXTRACT;

EUROPE; HERBAL MEDICINE; HUMAN; LIVER CIRRHOSIS; LIVER TUMOR; MEDICINAL PLANT; PATENT; PHYTOTHERAPY; REVIEW; UNITED STATES;

EUROPE; HERBAL MEDICINE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PATENTS AS TOPIC; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; UNITED STATES;

EID: 84871301024     PISSN: 22127984     EISSN: 18761429     Source Type: Journal    
DOI: 10.2174/2212798411204020091     Document Type: Review

References (132)

1. Zhang DY, Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatol 2012;doi: 10.1002/hep.25670.
2. Feng Y, Cheung K-F, Wang N, Liu P, Nagamatsu T, Tong Y. Chinese medicines as a resource for liver fibrosis treatment. Chinese Med 2009;4: 16.
3. Kim, K., Kim, K. Composition comprising Hovenia dulcis thunb. extract, Lindera obtusiloba blume extract, or herbal mixture extract thereof. US7846484 (2010).
4. Zhang, H. Medicinal composition for preventing and curing diabetes and its preparing method. CN1511576 (2004).
5. Bi, Y.D., Guo, F.C., Zhang, D.X. Preparation of wutian liver caring liquid. CN1509745 (2004).
6. Zhang, W.D., Li, H.X., Li, H.L, Zhang, C., Liu, R.H, Su, J., Xu, X. Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them.US7732458 (2010).
7. Hou, F.X. Pharmaceutical combination and preparation method thereof. CN101468183 (2009).
8. Luo, G.A., Liu, P., Hu, P., Wang, X.N., Zhang, M., Zhou, W.J. Chinese medicinal composition and application thereof. CN101940642 (2011).
9. Shu, J.C., He, Y.J., Lu, X., Li, C.K. Anti-liver fibrosis compound traditional Chinese medicine preparation and preparation method thereof. CN101664539 (2010).
10. Hattori, M., Sheu, C.-C., Yang, C. Compound from Antrodia camphorata and the use thereof. US7732482 (2010).
11. Myhill, P.R., Driscoll, W.J. Compositions for alleviating inflammation and oxidative stress in a mammal.US7923045 (2011).
12. Myhill, P.R., Driscoll, W.J. Methods for enhancing antioxidant enzyme activity and reducing c-reactive protein levels. US7579026 (2009).
13. Pan, I.-H., Hsieh, Y.-M., Huang, Z.-J., Chiu, H.-H., Ju, C.-T., Lu, C.-H., Tsai, P.-Y., Fan,W.-L., Peng, W.-H., Hsieh, M.-T. Pharmaceutical mixture for hepatitis treatment and its preparation method. US7799353 (2010).
14. Huang, R.B., Jiang, W.Z., Zhang, S.J., Li, J., Lin, X., Liu, X., Quanfang, H., Yanping, R., Jianchun, H., Yi S., Hongdi, T., Lin, J. Drug for treating hepatitis B. CN101199630 (2008).
15. Zabrecky, G. Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and nonalcoholic steatohepatitis.US7078064 (2006).
16. Ahmad, H., Elchagea, I., Hamza, E. Botanical drug compositions for treatments of liver and mmunological disorders. US7744929 (2010).
17. Hsu, S.-L. Pharmaceutical use of Graptopetalum and related plants. US7364758 (2008).
18. Bui, C.V., Cuong, Q. Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver. US8012510 (2011).
19. Zhao, S.L. Medicine against liver fibrillation. CN1456220 (2003).
20. Zhang, J., Yan, Q.C. Medicament for treating hyperlipemia, fatty liver, liver damnification and preparation thereof. CN101317998 (2008).
21. An, Y.W. Hepatosis treating Chinese medicine tablet. CN1706404 (2005).
22. Lan, Y.F. Medicine for treating hepatitis B and its preparing process. CN1308951 (2001).
23. Liu P, Hu YY, Ni LQ. On establishing comparative reference system for syndrome classification study from the thinking characteristics of syndrome differentiation dependent therapy. Zhongguo Zhongxiyi Jiehe Zazhi 2006;26: 451-4 (in Chinese).
24. Zhang Q, Liu P, Chen HF, Chen L, Cao S H, Liu Y, et al. Multianalysis of characteristics of traditional Chinese medical syndrome of hepatocirrhosis. Zhongguo Zhongxiyi Jiehe Ganbing Zaizhi 2003;13: 69-72 (in Chinese).
25. Yang, H.S. Anti-hepatitis B nanometer Chinese medicine and production method thereof. CN101773656 (2010).
26. Zhang, B.X. Medicament for treating liver disease. CN101199606 (2008).
27. Zhang, B.X. Traditional Chinese medicinal composition for treating hepatitis and its preparation. CN101214288 (2008).
28. Cheng, M.L., Ding, Y.S., Li, C.X. Chinese medicine for treating hepatofibrosis and hepatocirrhosis. CN1346658 (2002).
29. Wang, H.Z. Medicament for treating chronic hepatitis. CN101732454 (2010).
30. Yan, K.F., Yan, Z.K., Zhou, L.Y., Zhou, X.L. Medicine for treating liver diseases and production method thereof. CN101721652 (2010).
31. Li, C.Q., Song, L.F., Liu, X.X. Compound Chinese medicine for treating chronic liver disease and preparation.CN1814049 (2006).
32. Fu, L.J., Fu, J.J. Traditional Chinese medicine composition for soothing liver and strengthening spleen and nourishing qi and promoting blood circulation and preparation method thereof. CN101683437 (2010).
33. Pan, C., Zhang, Y.Y., Sun, Y., Yao, L.F. Liver fibrosis treating prepn and its process. CN1706443 (2005).
34. Wu, D.X. Liver softening plaster and its prepn. CN1772054 (2006).
35. Jun, Y., Gu, Z.X., He, L., Zhang, J. Traditional Chinese medicine compound preparation for treating viral hepatitis and complication. CN101693094 (2010).
36. Luo, Y., Wang, L., Yang, J.T. Traditional Chinese medicine composition for treating hepatic fibrosis after hepatitis treatment. CN101757544 (2010).
37. Qian, Y.X. Traditional Chinese medicine for treating hepatitis B and preparation method thereof. CN101390970 (2009).
38. Xuan, Z.Y., Wang, Y. Medicine for treating hepatic fibrosis. CN101332248 (2008).
39. Gu, Z.X., He, L., Jun, Y., Zhang, J. Compound Chinese medicinal preparation for treating fatty liver, alcoholic hepatitis and complications. CN101745077 (2010).
40. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol 2009;126: 5-17.
41. Feng Y, Luo W, Zhu S. Explore new clinical application of Huanglian and corresponding compound prescriptions from their traditional use. Zhongguo Zhong Yao Za Zhi 2008;33: 1221-5. [In Chinese].
42. Ye X, Feng Y, Tong Y, Ng KM, Tsao S, Lau GK, et al. Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats. J Ethnopharmacol 2009;124(1): 130-6.
43. Feng Y, Siu KY, Ye X, Wang N, Yuen MF, Leung CH, et al. Hepatoprotective effects of berberine on carbon tetrachlorideinduced acute hepatotoxicity in rats. Chin Med 2010;5: 33.
44. Feng Y, Wang N, Ye X, Li H, Feng Y, Cheung F, et al. Hepatoprotective effect and its possible mechanism of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced chronic liver hepatotoxicity in rats. J Ethnopharmacol. 2011;138(3):683-90.
45. Wang N, Feng Y, Lau EP, Tsang C, Ching Y, Man K, et al. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr Cancer Ther 2010;9(4): 354-64.
46. Wang N, Feng Y, Zhu M, Tsang CM, Man K, Tong Y, et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 2010;111(6):1426-36.
47. Zhu M, Wang N, Tsao S-W, Yuen M-F, Feng Y, Wan TSK, et al. Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Exp Ther Med 2011;2: 27-32.
48. Feng, Y., Wang, N. The new use of coptidis rhizoma total alkaloids. CN10234298 (2012).
49. Park P, Nan J, Park E, Kang H, Kim J, Ko G, et al. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Pharmacol Toxicol 2000;87: 261-8.
50. Dai C-L, Xiong H-Y, Tang L-F, Zhang X, Liang Y-J, Zeng M-S, et al. Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent eVect on doxorubicin pharmacokinetics in mice. Cancer Chemother Pharmacol 2007;60: 741-50.
51. Wang J, Chen B, Cheng J, Xu W, Sun X. Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoproteindependent Resistance to adriamycin in human lukemia cell line K562/A02. Ai Zheng 2008;27: 491-5 (in Chinese).
52. Petra HP, Gerhard W, Thomas E, Judith MR, Hermann S. Natural Products in Structure-Assisted Design of Molecular Cancer Therapeutics. Curr Pharm Design 2010;16: 1718-41.
53. Zhu Y, Zhang Z, Zhang M, Dale EM,Wang M-W. High throughput screening for bioactive components from traditional chinese medicine. Comb Chem High Throughput Screen 2010;13: 837-48.
54. Ma, Y.M., Wang, T.M., Zhang, Y.Y. Detection of blood plasma Danshensu and Salvianolic acid B dissipating blood stasis botanical. US7993928 (2011).
55. Ahmad, H., Elchagea, I., Hamza, E. Botanical drug compositions for treatments of liver and immunological disorders. US7744929 (2010).
56. He, M., Huang, Q.F., Huang, R.B., Liao, M., Lin, X., Zhang, S.J. Application of wild sesame seed extract in preparation of antihepatic fibrosis medicament. CN101810653 (2010).
57. Fang, B.W. Chinese medicine composition for treating hepatic fibrosis, and preparation method and applications thereof. CN101716319 (2010).
58. Wang, Y.S., Jian, H., Luo, X.J., Rao, Y., Fan, M.M., Zhang, G.S., et al. Preparation method of effective part of radix bupleuri and application thereof. CN101628021 (2010).
59. Ou, B., Zhong, J., Ma, S.H., Ye, Z.W. Application of Herba abri capsule in preparing medicament for preventing and treating liver fibrosis. CN101468106 (2009).
60. Hu, Y.Y., Liu, P., Li, X.M., Feng, Q., Peng, J.H., XU, L.M., et al. Medicine composition for treating chronic liver disease. CN101361782 (2009).
61. Huang, J.X. Medicine for treating diseases of liver, gall bladder and pancreas and cancer metastasis. CN101088551 (2007).
62. Wang, L.S., Liu, Y.H., Cheng, D.Y., Di, L., JI, H., Liu, X.Y. Total effective component of Chinese lizardtail herb and its prepn process and medicinal application. CN101019958 (2007).
63. Guan, S.X. Medicine composition for treating hepatic disease. CN101015666 (2007).
64. Chen, Z.P., Sun, Q., Zhang, C.S., Luo, C., Yang, Z.R. Chinese medicine preparation for preventing and treating chronic liver fibrosis and cirrhosis.CN1985871 (2007).
65. Zhang, S.X., Xiong, G.Y. Method for preparing total flavone of bidens bipinnata. CN101185665 (2008).
66. Liu, H.W. Chinese medicine red sage-astragalus root prepn for treating liver fibrosis and liver cirrhosis and its prepn process. CN1973857 (2007).
67. Liu, Z.Y. A Medicine for treatment of fatty liver and its preparation method. CN1943762 (2007).
68. Zhou, X.M. Chinese medicine composition for treating hepatic fibrosis and its prepn process. CN1931350 (2007).
69. Zhang, N., Wang, C.R., Liu, P., Bian, H.S., Zhang, J.H., Yuan, X.R., et al. Chinese medicine compound preparation for treating chronic hepatic disease and its preparing method. CN1899415 (2007).
70. Chen, F.H., Li, J., Yuan, L.P. Application of spanishneedles herb flavonid in preparing medicine for preventing and treating liver fibrosis. CN1887302 (2007).
71. Yuan, P., Mao, R.G., Ren, Q.P., Lin, D.H., Zhang, H., Qian, X.P., et al. Chinese medicine composition and its prepn process and application. CN1887316 (2007).
72. Liu, P., Wang, B., Mu, Y.P., Wang, L., Long, A.H., LI, F.H. Medicine for treating cholestasis and hepatic fibrosis and method for preparing the same. CN1827132 (2006).
73. Song, C.G., Huang, M., Wang, W.Q., Xia, Z.X. Chinese medicine suppository for treating liver fiberosis and hysteromyoma and preparing method. CN1814244 (2006).
74. Tian, Z.K. Synthesis of oleanolic acid succinic acid monoester and its medicinal preparation for treating chronic and acute hepatitis. CN1715291 (2006).
75. Yang, Y.A., Zhang, X.Q., Chen, Z.L. Method of preparing general phenolic acid of red sange root for treating hepatic fibrosis. CN1563075 (2005).
76. Liu, C.Y., Gu, Z.L., Zhou, W.X. Application of flatstem milkvetch seed and its extract in the preparation of anti hepatic fibrosis medicine and anticancer medicine. CN1544011 (2004).
77. Wang, W.X., Shi, D.Z., Hu, J.P., Liu, F., Ming, Z.J. Medicine for preventing fibrous liver and preparing method thereof. CN1530112 (2004).
78. Zhang, H. Medicinal composition for preventing and curing liver fibrosis and its preparing method. CN1511574 (2004).
79. Zhang, C., Zhang, W.D., Su, J. Fleabane extract and dicaffeoylquinic acid medicine composition and its application. CN1476842 (2004).
80. Liu, Q.H., Dai, J.Z., Wu, W.W. Chinese herbal preparation of centella asiatica glucoside against fibrosis of lung and liver. CN1439376 (2003).
81. Kim, M.-Y., Park, B.-Y., Moon, C.-H., Park, E.-K., Kim, K.-M.Composition comprising Melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity.US7485327 (2009).
82. Son, C.G. Compositions for treating liver fibrosis or cirrhosis. US7842315 (2010).
83. Lee, H.W. Functional food composition having effects of relieving alcohol-induced hangover symptoms and improving liver function. US7234931 (2007).
84. Henderson, T.R., Corson, B.E. L-ergothioneine, milk thistle, and Sadenosylmethionine for the prevention, treatment and repair of liver damage.US7563779 (2009).
85. Pan, I.-H., Hsieh, Y.-M., Huang, Z.-J., Chiu, H.-H., Ju, C.-T., Lu, C.-H., et al. Method for producing extracts of Boehmeria frutescens thunberg or Boehmeria nivea for hepatitis treatment.US7431946 (2008).
86. Kwak, T., Park, M. Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity. US8029832 (2011).
87. Myhill, P.R., Driscoll, W.J. Preparation of compositions to alleviate inflammation and oxidative stress in a mammal. US7384655 (2008).
88. Du J, Liu P, Sun M, Tao Q, Zhang L, Chen G, et al. Chinese herbal medicine Xiayuxue Decoction inhibits liver angiogenesis in rats with carbon tetrachloride-induced liver fibrosis. Zhong Xi Yi Jie He Xue Bao 2011;9: 878-87 [in Chinese].
89. Zhao Y, Wang Y, Wang Q, Liu Z, Liu Q, Deng X. Hepatic stellate cells produce vascular endothelial growth factor via phosphop44/42 mitogen-activated protein kinase/cyclooxygenase-2 pathway. Mol Cell Biochem 2012;359: 217-23.
90. Andersen E, Ruhwald M, Moessner B, Christensen P, Andersen O, Eugen-Olsen J, et al. Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1. Eur J Clin Microbiol Infect Dis 2011;30: 761-6.
91. Su, M. Medicinal composition for treating hepatitis B and its preparing method. CN1820779 (2006).
92. Hao H, Xiao Z, Li P, Wang G. Translational Research Insights into Pharmacokinetic Herb-Drug Interactions. Curr Drug Metab 2011;12: 850-70.
93. Guan J, Chen J. Translational research and its effects on medicine in China. Chin Med J (Engl) 2011;124: 3170-5.
94. Miller LH, Su X. Artemisinin: Discovery from the Chinese Herbal Garden. Cell 2011;146: 855-8.
95. Shen Z-X, Chen G-Q, Ni J-H, Li X-S, Xiong S-M, Qiu Q-Y, et al. Use of Arsenic Trioxide (As2O3) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients. Blood Cell Biochem 1997;89: 3354-60.
96. Zhang X-W, Yan X-J, Zhou Z-R, Yang F-F, Wu Z-Y, Sun H-B, et al. Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML. Science 2010;328: 240-3.
97. Zhang, S.X., Cui, N.N., Han, Y.X. Production and usage for largeleaf liver soft capsules. CN1981804 (2007).
98. State Food and Drug Administration. Guojia Zhongchengyao Biaozhun Huibian Neike Gandan Fence.1st ed. Huaxue Gongye Chubanshe: Beijing 2002 (in Chinese).
99. Wang, J. Zhuzigantai capsule and its preparing technology. CN1850205 (2006).
100. She, F., Hsieh, K.-Y., Chien, P.-J., Tsao, C.-Y., Chin, K.-L. Protein ACA1 of Antrodia camphorata. US7531627 (2009).
101. Hsu, S.-L. Pharmaceutical use of water-soluble fraction of Graptopetalum.US7588776 (2009).
102. Wei, L.X., Du, Y.Z., Xiao, Y.C., Zou, X.Y. Tibetan capillary extract and preparation method, medicine composition and use thereof. CN101396428 (2009).
103. Free, E. Compositions and methods for the treatment of fibromyalgia.US7297352 (2007).
104. Li, C.D. New medicine for curing chronic hepatitis B and its preparation method. CN1281701 (2001).
105. Kolosovskij, E.H.D., Shabrov, A.V., Radchenko, V.G. Agent for treatment of patients with hepatitis and fibrosis symptoms. RU2164802 (2001).
106. Huang, Z.Y. Decocted pill medicine for treating excess syndrome of hepatitis B. CN1371726 (2002).
107. Meng, Z.Q., Ding, Y.P. Soft-extract for treating hepatitis B and preparation process thereof. CN1385205 (2002).
108. Hu, F.G., Hu, G., Hu, X. Externally applied Chinese patent medicine for treating liver disease and preparation method thereof. CN101822755 (2010).
109. Huang, Y. Chinese medicament for treating ascites due to cirrhosis.CN101732626 (2010).
110. Xu, L.H. Medicine for treating liver disease. CN1385191 (2002).
111. Chen, J.M., Han, J., Ding, J.B. Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS. CN1460514 (2003).
112. Duan, S.P., Liang, H.J., Qiao, H.C., Tian, Z.W., Yang, D.K. Chinese patent medicament for treating hepatic fibrosis. CN101703737 (2010).
113. Wang, L.T., Chen, J.J., Gao, Y.Q., Zhao, G., Zhang, B. Compound preparation for treating liver fibrosis and its preparing method. CN1682868 (2005).
114. Lin, S.N., Liao, D.Y., Wang, Z.C., Zhu, Y.P. Medicinal composition for treating hepatopathy. CN101596230 (2009).
115. Gu, J.W. Ultra-fine grain traditional Chinese medicine defibrination paste used for treating liver cirrhosis. CN101530594 (2009).
116. Xu, S.M., Xie, P., Lu, W., Cao, P.D. Liver-protecting tea and preparation method thereof. CN101438748 (2009).
117. Jiang, B. Pure medicinal formulation for treating hepatopathy. CN101406516 (2009).
118. Zheng, X.Q., Sang, S.X., Chen, Y.J. Chinese traditional medicine for treating chronic liver disease and anti hepatic fibrosis. CN1539483 (2004).
119. Zhang, J. Theory and medicine for treating high blood fat, fatty liver, liver fibrosis and preparation method. CN1686273 (2005).
120. An, Y.W. Hepatosis treating soft Chinese medicine capsule. CN1706405 (2005).
121. Gao, T.Y. Sanjialongdan Ruangan pill. CN101306130 (2008).
122. Zhang, H.W., Li, Q.J., Liu, C.Y., Liang, M., Wang, R.D., Wang, L.F., et al. Medication for treating hepatic fibrosis, and preparation method. CN1726999 (2006).
123. Lin, L.J., Ji, X.Q. Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same. CN101278982 (2008).
124. Zhang, K. Application of rubus crataegifolius root in preparing liver-protecting health products. CN101264144 (2008).
125. Xu, X.T. Caterpillar fungus chemical fiber capsule and preparation technique. CN101264212 (2008).
126. Jin, G.Z. Medicine preparation for treating hepatitis B, and method of preparing the same. CN101244186 (2008).
127. Guo, C.Y., Zhong, M.Z., Huang, P.X., Shen, Z.Y. Medication for curing hepatic fibrosis and hepatic cirrhosis, and prepartion method. CN1795896 (2006).
128. Li, P.T., Qin, S.B., Lu, H., Cai, D.Y., Tang, H.L., He, Y. Chinese medicine composition for treating liver fibrosis and portal vein hypertension and its prepn. CN1772042 (2006).
129. Xuan, Z.Y., Wang, Y. Medicine for treating hepatic fibrosis. CN101091780 (2007).
130. Han, C.L. Hepatitis B treating Chinese herbal medicine. CN1857687 (2006).
131. Cheng, D.S., Li, Y.G., Xue, J.D. Medicine for anti-liver fibrosis. CN1977924 (2007).
132. Li, C., Li, S.H., He, C.J. Chinese medicine for treating hepatic fibrosis. CN1969976 (2007).